William Li
Vermögen: 103 275 $ am 30.06.2026
Vermögen: 103 275 $ am 30.06.2026
William W.
Li is the founder of The Angiogenesis Foundation, established in 1994, serving as President & Medical Director.
Current jobs include Independent Director at Ceapro, Inc. since 2014, Independent Director at Cypherpunk Technologies, Inc. since 2017, and Scientific Advisor at The Courtagen Group LLC.
Former jobs include Director at IBOD Imaging, Inc. from 2003 to 2006, Director at DOBI Medical Systems, Inc., Independent Non-Executive Director at Medicenna Therapeutics Corp.
from 2017 to 2019, Independent Director at COSCIENS Biopharma, Inc., and Director at Æterna Zentaris, Inc. Education includes undergraduate studies at Harvard College and a doctorate from the University of Pittsburgh School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.07.2026 | 168’750 ( 0.16% ) | 103 275 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CEAPRO INC. | Direktor/Vorstandsmitglied | 20.11.2014 |
| CYPHERPUNK TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 01.01.2017 |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
The Angiogenesis Foundation
The Angiogenesis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in disrupting disease through angiogenesis | Gründer | 01.01.1994 |
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Direktor/Vorstandsmitglied | 24.09.2019 |
IBOD Imaging, Inc.
IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Direktor/Vorstandsmitglied | 26.06.2006 |
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Direktor/Vorstandsmitglied | - |
DOBI Medical Systems, Inc.
DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
IBOD Imaging, Inc.
IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Health Technology |
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Ceapro, Inc.
Ceapro, Inc. BiotechnologyHealth Technology Develops and commercializes active ingredients and anti-aging products for for healthcare and cosmetic industries | Health Technology |
DOBI Medical Systems, Inc.
DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Health Technology |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Angiogenesis Foundation
The Angiogenesis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in disrupting disease through angiogenesis | Commercial Services |
Leap Therapeutics, Inc.
Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen